# Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

> **NCT02291133** · PHASE1,PHASE2 · COMPLETED · sponsor: **Masa Bosnjak** · enrollment: 25 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **PROCEDURE:** Electrochemotherapy
- **DEVICE:** Cliniporator Vitae®
- **DRUG:** Bleomycin PHC 15 e. (United States Pharmacopeia - USP)

## Key facts

- **NCT ID:** NCT02291133
- **Lead sponsor:** Masa Bosnjak
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2019-09
- **Final completion:** 2020-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02291133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02291133, "Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02291133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*